Jason P Perry

US Patent:

7711661, May 4, 2010

Filed:

May 2, 2007

Appl. No.:

11/743421

Inventors:

Charles A. Gentile - Plainsboro NJ, US
Jason Perry - Princeton NJ, US
Stephen W. Langish - Easthampton NJ, US
Kenneth Silber - Hopewell NJ, US
William M. Davis - East Windsor NJ, US
Dana Mastrovito - Yardley PA, US

Assignee:

The Trustees of Princeton University - Princeton NJ

International Classification:

G06F 15/18
G01J 1/42
G01T 1/00

US Classification:

706 12, 250394

Abstract:

A system for identifying radionuclide emissions is described. The system includes at least one processor for processing output signals from a radionuclide detecting device, at least one training algorithm run by the at least one processor for analyzing data derived from at least one set of known sample data from the output signals, at least one classification algorithm derived from the training algorithm for classifying unknown sample data, wherein the at least one training algorithm analyzes the at least one sample data set to derive at least one rule used by said classification algorithm for identifying at least one radionuclide emission detected by the detecting device.

US Patent:

7842672, Nov 30, 2010

Filed:

Jul 6, 2007

Appl. No.:

11/825395

Inventors:

Constantine G. Boojamra - San Francisco CA, US
James M. Chen - San Ramon CA, US
Alan X. Huang - San Mateo CA, US
Choung U. Kim - San Carlos CA, US
Kuei-Ying Lin - Sunnyvale CA, US
Richard L. Mackman - Millbrae CA, US
David A. Oare - Belmont CA, US
Jason K. Perry - San Francisco CA, US
Oliver L. Saunders - San Mateo CA, US
Sundaramoorthi Swaminathan - Burlingame CA, US
Lijun Zhang - Palo Alto CA, US

Assignee:

Gilead Sciences, Inc. - Foster City CA

International Classification:

A01N 43/04
A61K 31/70

US Classification:

514 43, 514 45, 514 46, 514 47, 514 48, 514 49, 514 50, 514 51, 514 52

Abstract:

A compound of Formula I, Formula II, Formula III, or Formula IV:.

US Patent:

7877340, Jan 25, 2011

Filed:

Apr 16, 2010

Appl. No.:

12/761717

Inventors:

Charles A. Gentile - Plainsboro NJ, US
Jason Perry - Princeton NJ, US
Stephen W. Langish - Eastampton NJ, US
Kenneth Silber - Hopewell NJ, US
William M. Davis - East Windsor NJ, US
Dana Mastrovito - Yardley PA, US

Assignee:

Princeton University - Princeton NJ

International Classification:

G06E 1/00
G06E 3/00
G06F 15/18
G06F 7/00
G01J 1/42
G01T 1/00

US Classification:

706 16, 250394

Abstract:

A system for identifying radionuclide emissions is described. The system includes at least one processor for processing output signals from a radionuclide detecting device, at least one training algorithm run by the at least one processor for analyzing data derived from at least one set of known sample data from the output signals, at least one classification algorithm derived from the training algorithm for classifying unknown sample data, wherein the at least one training algorithm analyzes the at least one sample data set to derive at least one rule used by said classification algorithm for identifying at least one radionuclide emission detected by the detecting device.

US Patent:

8324179, Dec 4, 2012

Filed:

Feb 8, 2008

Appl. No.:

12/524545

Inventors:

James M. Chen - San Ramon CA, US
Alan X. Huang - San Mateo CA, US
Richard L. Mackman - Millbrae CA, US
Jay Parrish - Redwood City CA, US
Jason K. Perry - San Francisco CA, US
Oliver L. Saunders - San Mateo CA, US
David Sperandio - Palo Alto CA, US

Assignee:

Gilead Sciences, Inc. - Foster City CA

International Classification:

A01N 43/04
A61K 31/70

US Classification:

514 43, 514 44 R, 514 45, 514 49

Abstract:

The invention provides unsaturated phosphonates of Formula I or a tautomer or pharmaceutically acceptable salt thereof, as described herein, as well as pharmaceutical compositions comprising the compounds, and therapeutic methods comprising administering the compounds. The compounds have anti-viral properties and are useful for treating viral infections (e. g. HCV) in animals (e. g. humans).

US Patent:

20110258151, Oct 20, 2011

Filed:

Jan 21, 2011

Appl. No.:

13/011431

Inventors:

Charles A. Gentile - Plainsboro NJ, US
Jason Perry - Princeton NJ, US
Stephen W. Langish - Eastampton NJ, US
Kenneth Silber - Hopewell NJ, US
William M. Davis - East Windsor NJ, US
Dana Mastrovito - Yardley PA, US

International Classification:

G06F 15/18

US Classification:

706 12

Abstract:

A system for identifying radionuclide emissions is described. The system includes at least one processor for processing output signals from a radionuclide detecting device, at least one training algorithm run by the at least one processor for analyzing data derived from at least one set of known sample data from the output signals, at least one classification algorithm derived from the training algorithm for classifying unknown sample data, wherein the at least one training algorithm analyzes the at least one sample data set to derive at least one rule used by said classification algorithm for identifying at least one radionuclide emission detected by the detecting device.

US Patent:

20120238552, Sep 20, 2012

Filed:

Mar 19, 2012

Appl. No.:

13/423606

Inventors:

Jason M. PERRY - Cambridge MA, US
Daniel R. DEAVER - Franklin MA, US
Magall B. HICKEY - Medford MA, US
Julius F. REMENAR - Framingham MA, US
Jennifer VANDIVER - Arlington MA, US

Assignee:

ALKERMES, INC. - Waltham MA

International Classification:

A61K 31/496
A61P 25/24
A61P 25/00
A61P 25/22
A61K 31/5513
A61P 25/18

US Classification:

514220, 51425307

Abstract:

The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.

US Patent:

20220226337, Jul 21, 2022

Filed:

Dec 14, 2021

Appl. No.:

17/550591

Inventors:

- Foster City CA, US
Taryn Campbell - Seattle WA, US
Jayaraman Chandrasekhar - Redmond WA, US
Christopher T. Clark - Seattle WA, US
Julian A. Codelli - Seattle WA, US
Kevin S. Currie - North Bend WA, US
Jeffrey E. Kropf - Issaquah WA, US
Yasamin Moazami - Seattle WA, US
Nicole Nava - Seattle WA, US
Leena Patel - Seattle WA, US
Stephane Perreault - Brier WA, US
Jason K. Perry - San Francisco CA, US
Kassandra F. Sedillo - Princeton NJ, US
Natalie Seeger - Salt Lake City UT, US
Kirk L. Stevens - Bothell WA, US
Jennifer Anne Treiberg - Redmond WA, US
Suet C. Yeung - Redmond WA, US
Zhongdong Zhao - Bellevue WA, US

International Classification:

A61K 31/5377
A61K 31/343
A61K 31/353
A61K 31/357
A61K 31/416
A61K 31/4375
A61K 31/4709
A61K 31/513
A61K 31/519
A61K 31/538
A61K 31/541
A61K 45/06
C07D 295/00
C07D 307/87
C07D 319/18
C07D 405/10
C07D 407/10
C07D 413/14
C07D 471/04

Abstract:

The present disclosure provides a compound of Formula (I):or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.

US Patent:

20230041518, Feb 9, 2023

Filed:

Jul 19, 2021

Appl. No.:

17/379175

Inventors:

- Foster City CA, US
Taryn Campbell - Seattle WA, US
Jayaraman Chandrasekhar - Redmond WA, US
Christopher T. Clark - Seattle WA, US
Julian A. Codelli - Seattle WA, US
Kevin S. Currie - North Bend WA, US
Jeffrey E. Kropf - Issaquah WA, US
Yasamin Moazami - Seattle WA, US
Nicole Nava - Seattle WA, US
Leena Patel - Seattle WA, US
Stephane Perreault - Brier WA, US
Jason K. Perry - San Francisco CA, US
Kassandra F. Sedillo - Princeton NJ, US
Natalie Seeger - Salt Lake City UT, US
Kirk L. Stevens - Bothell WA, US
Jennifer Anne Treiberg - Redmond WA, US
Suet C. Yeung - Redmond WA, US
Zhongdong Zhao - Bellevue WA, US

International Classification:

A61K 31/47
A61K 31/4375
A61K 31/4709
A61K 31/501
A61K 31/506
A61K 31/517
A61K 31/519
A61K 31/5355
A61K 31/541
A61K 45/06
C07D 215/14
C07D 401/10
C07D 401/12
C07D 401/14
C07D 405/14
C07D 407/14
C07D 409/14
C07D 413/12
C07D 413/14
C07D 417/12
C07D 471/04
C07D 487/04

Abstract:

The present disclosure provides a compound of Formula (I):or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.